These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34793353)

  • 21. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
    Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
    Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival.
    Gavazzi F; Capretti G; Giordano L; Ridolfi C; Spaggiari P; Sollai M; Carrara S; Nappo G; Bozzarelli S; Zerbi A
    Dig Liver Dis; 2022 Jun; 54(6):826-833. PubMed ID: 34219044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome after surgery for invasive intraductal papillary mucinous neoplasia compared to conventional pancreatic ductal adenocarcinoma - A Swedish nationwide register-based study.
    Holmberg M; Radkiewicz C; Strömberg C; Öman M; Ghorbani P; Löhr JM; Sparrelid E
    Pancreatology; 2023 Jan; 23(1):90-97. PubMed ID: 36522260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancer.
    Habib JR; Rompen IF; Javed AA; Grewal M; Kinny-Köster B; Andel PCM; Hewitt DB; Sacks GD; Besselink MG; van Santvoort HC; Daamen LA; Loos M; He J; Büchler MW; Wolfgang CL; Molenaar IQ
    J Gastroenterol Hepatol; 2024 Nov; 39(11):2360-2366. PubMed ID: 39086101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
    Winter JM; Jiang W; Basturk O; Mino-Kenudson M; Fong ZV; Tan WP; Lavu H; Vollmer CM; Furth EE; Haviland D; Klimstra DS; Jarnagin WR; Lillemoe KD; Yeo CJ; Fernandez-Del Castillo C; Allen PJ
    Ann Surg; 2016 Apr; 263(4):793-801. PubMed ID: 26135696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refined prognostic staging for resected pancreatic cancer by modified stage grouping and addition of tumour grade.
    König AK; Gros H; Hinz U; Hank T; Kaiser J; Hackert T; Bergmann F; Büchler MW; Strobel O
    Eur J Surg Oncol; 2022 Jan; 48(1):113-120. PubMed ID: 34344573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
    Allen PJ; Kuk D; Castillo CF; Basturk O; Wolfgang CL; Cameron JL; Lillemoe KD; Ferrone CR; Morales-Oyarvide V; He J; Weiss MJ; Hruban RH; Gönen M; Klimstra DS; Mino-Kenudson M
    Ann Surg; 2017 Jan; 265(1):185-191. PubMed ID: 27163957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
    Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
    Ann Surg Oncol; 2014 Jul; 21(7):2444-52. PubMed ID: 24562937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma.
    Rowan DJ; Hartley CP; Aldakkak M; Christians KK; Evans DB; Tsai S; Hagen CE
    Ann Diagn Pathol; 2020 Jun; 46():151485. PubMed ID: 32172219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking Status and the Incidence of Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm.
    Nakagawa T; Masuda A; Toyama H; Shiomi H; Zen Y; Sofue K; Takenaka M; Kobayashi T; Yagi Y; Yamanaka K; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
    Pancreas; 2017 Apr; 46(4):582-588. PubMed ID: 28099253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
    Shi S; Hua J; Liang C; Meng Q; Liang D; Xu J; Ni Q; Yu X
    Ann Surg; 2019 May; 269(5):944-950. PubMed ID: 29334560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort.
    Kwon W; He J; Higuchi R; Son D; Lee SY; Kim J; Kim H; Kim SW; Wolfgang CL; Cameron JL; Yamamoto M; Jang JY
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):418-427. PubMed ID: 30118171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma.
    Holmberg M; Ghorbani P; Gilg S; Del Chiaro M; Arnelo U; Löhr JM; Sparrelid E
    Pancreatology; 2021 Oct; 21(7):1371-1377. PubMed ID: 34426077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system.
    Rochefort MM; Ankeny JS; Kadera BE; Donald GW; Isacoff W; Wainberg ZA; Hines OJ; Donahue TR; Reber HA; Tomlinson JS
    Ann Surg Oncol; 2013 Dec; 20(13):4322-9. PubMed ID: 23943022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer.
    Habib JR; Rompen IF; Campbell BA; Andel PCM; Kinny-Köster B; Damaseviciute R; Brock Hewitt D; Sacks GD; Javed AA; Besselink MG; van Santvoort HC; Daamen LA; Loos M; He J; Quintus Molenaar I; Büchler MW; Wolfgang CL
    J Natl Cancer Inst; 2024 Nov; 116(11):1791-1797. PubMed ID: 39029923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]   [Full Text] [Related]  

  • 39. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
    Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y
    Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
    Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
    Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.